AF
ALBO

Allworth Financial’s Albireo Pharma Inc ALBO Stock Holding History

Allworth Financial’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-61
Closed -$1.32K – 3337
2022
Q4 		$1.32K Buy
61
+49
+408% +$1.04K ﹤0.01% 2385
2022
Q3 		$0 Buy
+12
New +$248 ﹤0.01% 3240

Other funds holding ALBO

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Allworth Financial's ALBO Position: Q1 2023 in Review

Allworth Financial sold out of Albireo Pharma Inc (ALBO) in Q1 2023, closing a stake of 61 shares — an estimated $1.32K sold.

Allworth Financial first reported a position in ALBO in Q3 2022 and held it in 2 quarters. The position peaked at $1.32K in Q4 2022. 3 funds tracked by Wall St. Rank hold ALBO as of Q1 2023.

  • Allworth Financial reported no remaining Albireo Pharma Inc position as of Q1 2023 after selling out during the quarter.
  • Allworth Financial sold 61 Albireo Pharma Inc shares in Q1 2023, an estimated $1.32K.
  • Allworth Financial first reported a position in Albireo Pharma Inc in Q3 2022 and held it in 2 quarters.
  • Allworth Financial's Albireo Pharma Inc position peaked at $1.32K in Q4 2022.
  • 3 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q1 2023.

Based on Allworth Financial's 13F filing for Q1 2023, filed 18 Apr 2023.